Showing 5691-5700 of 5956 results for "".
- EyePoint Pharmaceuticals Added to NASDAQhttps://modernod.com/news/eyepoint-pharmaceuticals-added-to-nasdaq/2479607/EyePoint Pharmaceuticals announced that it has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ: NBI). EyePoint’s addition to the NBI will become effective prior to market open on Monday, December 24, 2018. The NASDAQ Biotechnology Index is designed to track the perform
- Bausch Health to Purchase Majority of Synergy Pharmaceuticals’ Assets, Including Trulancehttps://modernod.com/news/bausch-health-to-purchase-majority-of-synergy-pharmaceuticals-assets-including-trulance/2479614/Bausch Health announced a deal to purchase nearly all of the assets of bankrupt drugmaker Synergy Pharmaceuticals for about $200 million in cash, with the transaction including the constipation treatment Trulance (plecanatide), according to FirstWord. Bausch Health CEO Joseph Papa noted that the
- Innovent Announces Two Clinical Studies with the Anti-VEGF Monoclonal Antibody IBI305, a Potential Avastin Biosimilarhttps://modernod.com/news/innovent-announces-two-clinical-studies-with-the-anti-vegf-monoclonal-antibody-ibi305-a-potential-avastin-biosimilar/2479615/Innovent Biologics announced that IBI305, a recombinant humanized anti-VEGF monoclonal antibody being developed as a potential biosimilar to Avastin (bevacizumab), has met predefined primary endpoints in two randomized, head to head, clinical trials comparing IBI30
- SECO International Partners With the American Society of Optometric Surgeons for SECO 2019https://modernod.com/news/seco-international-partners-with-the-american-society-of-optometric-surgeons-for-seco-2019/2479621/SECO International has announced that SECO, the educational conference providing ophthalmic professionals educational opportunities since 1924, has partnered with the American Society of Optometric Surgeons (ASOS) to bring hands-on demonstrations showing radiosurgical technology, Botox, and YAG l
- Wills Eye Hospital’s Training in Ophthalmology Voted #1 Top Eye Residency Program in Nationhttps://modernod.com/news/wills-eye-hospitals-training-in-ophthalmology-voted-1-top-eye-residency-program-in-nation/2479623/The Wills Eye at Jefferson Residency Program in Philadelphia has been voted the #1 medical education training program in ophthalmology in the nation, according to Doximity.com. The Wills Eye Hospital faculty serve as the department of Ophthalmology at Thomas Jefferson
- Center for Vision and Population Health at Prevent Blindness Established to Implement Strategies to Address Eye Healthhttps://modernod.com/news/center-for-vision-and-population-health-at-prevent-blindness-established-to-implement-strategies-to-address-eye-health/2476154/Healthy vision can be a key component to independence and well-being for people of all ages. However barriers such as poor access to eye care, lack of insurance coverage, and inconsistent policies for eye health can prevent early detection and treatment of eye disorders. Prevent Blindness,
- 4D Molecular Therapeutics Announces Collaboration to Advance Gene Therapies for Retinal Diseases with Oregon Health & Sciencehttps://modernod.com/news/4d-molecular-therapeutics-announces-collaboration-to-advance-gene-therapies-for-retinal-diseases-with-oregon-health-science/2476157/4D Molecular Therapeutics (4DMT) announced a research and development collaboration with the Casey Eye Institute and the Oregon National Primate Research Center at Oregon Health & Science University (OHSU). The collaboration will combine the complementary expertise of 4D Molecular Therapeutic
- Spark Therapeutics Gene Therapy Pioneers Win $1 Million Sanford Lorraine Cross Awardhttps://modernod.com/news/spark-therapeutics-gene-therapy-pioneers-win-1-million-sanford-lorraine-cross-award/2476159/Two women with a vision to make the blind see were the winners of the inaugural $1 million Sanford Lorraine Cross Award. Jean Bennett, MD, PhD, and Katherine A. High, MD, whose work with the RPE65 mutation has reversed an inherited form of blindness, accepted the award on December 4 at Sanford He
- Takeda Shareholders Back Shire Purchasehttps://modernod.com/news/takeda-shareholders-back-shire-purchase/2479627/Shareholders of Japanese pharmaceutical company Takeda overwhelmingly voted in favor of acquiring UK-based Shire. The deal, currently valued at about $58 billion dollars, makes Takeda a top 10 global drugmaker by sales. Takeda shareholders on Wednesday voted 88 percent in favor in of thee
- MDI Biological Laboratory Scientist Receives Scientific Innovation Award for Research on AMDhttps://modernod.com/news/mdi-biological-laboratory-scientist-receives-scientific-innovation-award-for-research-on-amd/2476162/Vicki P. Losick, PhD, has been named the inaugural recipient of an award from the William Procter Scientific Innovation Fund. The award will support her research at the MDI Biological Laboratory on age-related macular degeneration (AMD). The Procter Fund was established at the MDI Biologic